Filtered By:
Management: Tax
Therapy: Statin Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in Australia.
CONCLUSIONS: Applying a cross-sectorial government perspective budget impact assessment improves our understanding of fiscal changes attributed to ASCVD based on changes in premature mortality and work activity and how this influences lifetime tax contributions and public benefits. The main cost driver observed was associated with reduced ASCVD events that enabled people to remain productive and paying taxes. PMID: 33464137 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - January 20, 2021 Category: Health Management Tags: J Med Econ Source Type: research

Commercial framework: working in partnership with the pharmaceutical industry for the benefit of patients
The NHS in England spends around £18 billion on medicines a year. It must do everything it can to get access to innovative medicines for patients, while making sure it does so at great value and cost-effective prices to the NHS and taxpayers, writes Blake Dark, commercial medicines director for NHS England Related items fromOnMedica Pharmacists could offer high-dose statins direct to patients Clinicians need better options if we are to stop over-medication GPs need more time to treat complex needs Stroke survivors need more help taking medicine Prescription drug dependence linked to deprivation
Source: OnMedica Views - December 16, 2019 Category: Primary Care Source Type: news

Is Your Prescription a Hall Pass or Lottery Ticket?
As much as I love learning, I did not always love school. We moved a lot, and I was too shy to do well as the new kid. At a new high school during my freshmen year, I discovered the joys of the hall pass. Being handed one gave me a feeling of freedom. With it, I was safe to evade the pressures of the classroom and wander the halls aimlessly. If a teacher stopped me to see if I should be in class, all I had to do was show my hall pass, and I'd be on my way. I think of a hall pass as something that is assured to protect you. Let's say a hall pass works at least 8 out of 10 times. There are hall passes, and then, there are l...
Source: Healthy Living - The Huffington Post - September 17, 2015 Category: Consumer Health News Source Type: news

Death by a Thousand Cuts
It is likely that you don't realize what your state and our nation have lost in economic terms and research productivity as a result of recent cuts in the federal budget and budget instability brought on by a failure of Congress to pass a budget in a timely manner. Although some members of Congress strongly support increased funding for U.S. research, others argue that the time has come for the cost of basic biomedical research to be borne by industry and philanthropy. Those who make that argument either ignore, or are unaware, that this experiment has already been tried -- unsuccessfully. Nearly 80 years ago, Louisiana ...
Source: Science - The Huffington Post - October 24, 2014 Category: Science Source Type: news

The Effect of Tobacco Control Measures during a Period of Rising Cardiovascular Disease Risk in India: A Mathematical Model of Myocardial Infarction and Stroke
Conclusions Smoke-free laws and substantially increased tobacco taxation appear to be markedly potent population measures to avert future cardiovascular deaths in India. Despite the rise in co-morbid cardiovascular disease risk factors like hyperlipidemia and hypertension in low- and middle-income countries, tobacco control is likely to remain a highly effective strategy to reduce cardiovascular deaths.Please see later in the article for the Editors' Summary
Source: PLoS Medicine - July 9, 2013 Category: Internal Medicine Authors: Sanjay Basu et al. Source Type: research